Concepedia

Dennis Carney

DC

29

Publications

2.2K

Citations

19

H-Index

2000

Active since

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Monash University

The University of Texas MD Anderson Cancer Center

The Royal Melbourne Hospital

Dennis Carney is an author at Peter MacCallum Cancer Centre specializing in medicine, pathology, and health sciences.

ORCID

Top concepts

Publications per year

2000–2025

29

Publications

29

Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease

Andrew W. Roberts, John F. Seymour, Jennifer R. Brown et al. · Journal of Clinical Oncology · 2011 · 808 citations · Full text

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

Chan Y. Cheah, Kirsten Herbert, Kacey O’Rourke et al. · British Journal of Cancer · 2014 · 129 citations · Full text

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy

Dennis Carney, David Westerman, Constantine S. Tam et al. · Leukemia · 2010 · 105 citations

, , +10

OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action

Yan Zhou, Celia Garcı́a-Prieto, Dennis Carney et al. · JNCI Journal of the National Cancer Institute · 2005 · 102 citations

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the <scp>BCL</scp>2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory <scp>CD</scp>20<sup>+</sup> lymphoid malignancies

Andrew W. Roberts, Ranjana H. Advani, Brad S. Kahl et al. · British Journal of Haematology · 2015 · 98 citations · Full text

Rows per page

1–5 of 29